Despite today’s buyout offer, Celera has to rank as one of the biggest biotech busts of all time. Since CRA has about $325M of net current assets, the buyout price of $657M equates to an enterprise value of only $330M or so. That’s not a lot for a company that has lost $1B since its inception.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.